Regenerative medicine market projected to reach $62.69 billion by 2031

A new report from MarketsandMarkets forecasts significant growth in the global regenerative medicine market. The sector is expected to expand from $23.9 billion in 2026 to $62.69 billion by 2031, representing a compound annual growth rate (CAGR) of 21.3%.

Key growth drivers include the rise of personalized medicine, an increase in regulatory approvals, and strategic partnerships among major industry players. The oncology segment is identified as the fastest-growing therapeutic area, with a projected CAGR of 22.3%. As of 2025, North America held approximately 52.3% of the market share, while cell therapy accounted for about 47.6% of the market.

Despite the optimistic outlook, the report notes several constraints, such as high treatment costs, ethical and legal concerns, and a lack of long-term clinical data. Opportunities for future expansion include the integration of artificial intelligence, big data, and 3D printing technologies.